Service & Software

Global Gene Site-Directed Mutagenesis Services Market Research Report 2026

This report delivers a comprehensive overview of the global Gene Site-Directed Mutagenesis Services market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Gene Site-Directed Mutagenesis Services. The Gene Site-Directed Mutagenesis Services market size, estimates, and forecasts are provided in terms of revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Gene Site-Directed Mutagenesis Services market comprehensively. Regional market sizes by Type, by Application, , and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Gene Site-Directed Mutagenesis Services manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation
By Company
ACGT
Azenta Life Sciences
Biocompare
NovoPro Bioscience Inc.
Charles River
NZYtech
Thermofisher
Creatve Biolabs
Epoch Life Science
GeneToProtein
Genewiz
GenScript
Segment by Type
Synonymous Mutations
Missense Mutation
Nonsense Mutation
Segment by Application
Medical Industry
Biological Research
Others
By Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia & New Zealand
Rest of Asia
Europe
Germany
France
U.K.
Italy
Ireland
Russia
Rest of Europe
Latin America
Mexico
Brazil
Argentina
Rest of Latin America
Middle East & Africa
Israel
United Arab Emirates (UAE)
Saudi Arabia
Rest of MEA
Chapter Outline
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.
Chapter 3: Provides a detailed view of the competitive landscape for Gene Site-Directed Mutagenesis Services companies, covering revenue share, development plans, and mergers and acquisitions.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.
Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.
Chapter 12: Key findings and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Gene Site-Directed Mutagenesis Services Market Size Growth Rate by Type: 2021 vs 2025 vs 2032
1.2.2 Synonymous Mutations
1.2.3 Missense Mutation
1.2.4 Nonsense Mutation
1.3 Market by Application
1.3.1 Global Gene Site-Directed Mutagenesis Services Market Growth by Application: 2021 vs 2025 vs 2032
1.3.2 Medical Industry
1.3.3 Biological Research
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Gene Site-Directed Mutagenesis Services Market Perspective (2021–2032)
2.2 Global Gene Site-Directed Mutagenesis Services Growth Trends by Region
2.2.1 Global Gene Site-Directed Mutagenesis Services Market Size by Region: 2021 vs 2025 vs 2032
2.2.2 Gene Site-Directed Mutagenesis Services Historic Market Size by Region (2021–2026)
2.2.3 Gene Site-Directed Mutagenesis Services Forecasted Market Size by Region (2027–2032)
2.3 Gene Site-Directed Mutagenesis Services Market Dynamics
2.3.1 Gene Site-Directed Mutagenesis Services Industry Trends
2.3.2 Gene Site-Directed Mutagenesis Services Market Drivers
2.3.3 Gene Site-Directed Mutagenesis Services Market Challenges
2.3.4 Gene Site-Directed Mutagenesis Services Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Gene Site-Directed Mutagenesis Services Players by Revenue
3.1.1 Global Top Gene Site-Directed Mutagenesis Services Players by Revenue (2021–2026)
3.1.2 Global Gene Site-Directed Mutagenesis Services Revenue Market Share by Players (2021–2026)
3.2 Global Top Gene Site-Directed Mutagenesis Services Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
3.3 Global Key Players Ranking by Gene Site-Directed Mutagenesis Services Revenue
3.4 Global Gene Site-Directed Mutagenesis Services Market Concentration Ratio
3.4.1 Global Gene Site-Directed Mutagenesis Services Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Gene Site-Directed Mutagenesis Services Revenue in 2025
3.5 Global Key Players of Gene Site-Directed Mutagenesis Services Head Offices and Areas Served
3.6 Global Key Players of Gene Site-Directed Mutagenesis Services, Products and Applications
3.7 Global Key Players of Gene Site-Directed Mutagenesis Services, Date of General Availability (GA)
3.8 Mergers and Acquisitions, Expansion Plans
4 Gene Site-Directed Mutagenesis Services Breakdown Data by Type
4.1 Global Gene Site-Directed Mutagenesis Services Historic Market Size by Type (2021–2026)
4.2 Global Gene Site-Directed Mutagenesis Services Forecasted Market Size by Type (2027–2032)
5 Gene Site-Directed Mutagenesis Services Breakdown Data by Application
5.1 Global Gene Site-Directed Mutagenesis Services Historic Market Size by Application (2021–2026)
5.2 Global Gene Site-Directed Mutagenesis Services Forecasted Market Size by Application (2027–2032)
6 North America
6.1 North America Gene Site-Directed Mutagenesis Services Market Size (2021–2032)
6.2 North America Gene Site-Directed Mutagenesis Services Market Growth Rate by Country: 2021 vs 2025 vs 2032
6.3 North America Gene Site-Directed Mutagenesis Services Market Size by Country (2021–2026)
6.4 North America Gene Site-Directed Mutagenesis Services Market Size by Country (2027–2032)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Gene Site-Directed Mutagenesis Services Market Size (2021–2032)
7.2 Europe Gene Site-Directed Mutagenesis Services Market Growth Rate by Country: 2021 vs 2025 vs 2032
7.3 Europe Gene Site-Directed Mutagenesis Services Market Size by Country (2021–2026)
7.4 Europe Gene Site-Directed Mutagenesis Services Market Size by Country (2027–2032)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Ireland
8 Asia-Pacific
8.1 Asia-Pacific Gene Site-Directed Mutagenesis Services Market Size (2021–2032)
8.2 Asia-Pacific Gene Site-Directed Mutagenesis Services Market Growth Rate by Region: 2021 vs 2025 vs 2032
8.3 Asia-Pacific Gene Site-Directed Mutagenesis Services Market Size by Region (2021–2026)
8.4 Asia-Pacific Gene Site-Directed Mutagenesis Services Market Size by Region (2027–2032)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia & New Zealand
9 Latin America
9.1 Latin America Gene Site-Directed Mutagenesis Services Market Size (2021–2032)
9.2 Latin America Gene Site-Directed Mutagenesis Services Market Growth Rate by Country: 2021 vs 2025 vs 2032
9.3 Latin America Gene Site-Directed Mutagenesis Services Market Size by Country (2021–2026)
9.4 Latin America Gene Site-Directed Mutagenesis Services Market Size by Country (2027–2032)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Gene Site-Directed Mutagenesis Services Market Size (2021–2032)
10.2 Middle East & Africa Gene Site-Directed Mutagenesis Services Market Growth Rate by Country: 2021 vs 2025 vs 2032
10.3 Middle East & Africa Gene Site-Directed Mutagenesis Services Market Size by Country (2021–2026)
10.4 Middle East & Africa Gene Site-Directed Mutagenesis Services Market Size by Country (2027–2032)
10.5 Israel
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 ACGT
11.1.1 ACGT Company Details
11.1.2 ACGT Business Overview
11.1.3 ACGT Gene Site-Directed Mutagenesis Services Introduction
11.1.4 ACGT Revenue in Gene Site-Directed Mutagenesis Services Business (2021–2026)
11.1.5 ACGT Recent Development
11.2 Azenta Life Sciences
11.2.1 Azenta Life Sciences Company Details
11.2.2 Azenta Life Sciences Business Overview
11.2.3 Azenta Life Sciences Gene Site-Directed Mutagenesis Services Introduction
11.2.4 Azenta Life Sciences Revenue in Gene Site-Directed Mutagenesis Services Business (2021–2026)
11.2.5 Azenta Life Sciences Recent Development
11.3 Biocompare
11.3.1 Biocompare Company Details
11.3.2 Biocompare Business Overview
11.3.3 Biocompare Gene Site-Directed Mutagenesis Services Introduction
11.3.4 Biocompare Revenue in Gene Site-Directed Mutagenesis Services Business (2021–2026)
11.3.5 Biocompare Recent Development
11.4 NovoPro Bioscience Inc.
11.4.1 NovoPro Bioscience Inc. Company Details
11.4.2 NovoPro Bioscience Inc. Business Overview
11.4.3 NovoPro Bioscience Inc. Gene Site-Directed Mutagenesis Services Introduction
11.4.4 NovoPro Bioscience Inc. Revenue in Gene Site-Directed Mutagenesis Services Business (2021–2026)
11.4.5 NovoPro Bioscience Inc. Recent Development
11.5 Charles River
11.5.1 Charles River Company Details
11.5.2 Charles River Business Overview
11.5.3 Charles River Gene Site-Directed Mutagenesis Services Introduction
11.5.4 Charles River Revenue in Gene Site-Directed Mutagenesis Services Business (2021–2026)
11.5.5 Charles River Recent Development
11.6 NZYtech
11.6.1 NZYtech Company Details
11.6.2 NZYtech Business Overview
11.6.3 NZYtech Gene Site-Directed Mutagenesis Services Introduction
11.6.4 NZYtech Revenue in Gene Site-Directed Mutagenesis Services Business (2021–2026)
11.6.5 NZYtech Recent Development
11.7 Thermofisher
11.7.1 Thermofisher Company Details
11.7.2 Thermofisher Business Overview
11.7.3 Thermofisher Gene Site-Directed Mutagenesis Services Introduction
11.7.4 Thermofisher Revenue in Gene Site-Directed Mutagenesis Services Business (2021–2026)
11.7.5 Thermofisher Recent Development
11.8 Creatve Biolabs
11.8.1 Creatve Biolabs Company Details
11.8.2 Creatve Biolabs Business Overview
11.8.3 Creatve Biolabs Gene Site-Directed Mutagenesis Services Introduction
11.8.4 Creatve Biolabs Revenue in Gene Site-Directed Mutagenesis Services Business (2021–2026)
11.8.5 Creatve Biolabs Recent Development
11.9 Epoch Life Science
11.9.1 Epoch Life Science Company Details
11.9.2 Epoch Life Science Business Overview
11.9.3 Epoch Life Science Gene Site-Directed Mutagenesis Services Introduction
11.9.4 Epoch Life Science Revenue in Gene Site-Directed Mutagenesis Services Business (2021–2026)
11.9.5 Epoch Life Science Recent Development
11.10 GeneToProtein
11.10.1 GeneToProtein Company Details
11.10.2 GeneToProtein Business Overview
11.10.3 GeneToProtein Gene Site-Directed Mutagenesis Services Introduction
11.10.4 GeneToProtein Revenue in Gene Site-Directed Mutagenesis Services Business (2021–2026)
11.10.5 GeneToProtein Recent Development
11.11 Genewiz
11.11.1 Genewiz Company Details
11.11.2 Genewiz Business Overview
11.11.3 Genewiz Gene Site-Directed Mutagenesis Services Introduction
11.11.4 Genewiz Revenue in Gene Site-Directed Mutagenesis Services Business (2021–2026)
11.11.5 Genewiz Recent Development
11.12 GenScript
11.12.1 GenScript Company Details
11.12.2 GenScript Business Overview
11.12.3 GenScript Gene Site-Directed Mutagenesis Services Introduction
11.12.4 GenScript Revenue in Gene Site-Directed Mutagenesis Services Business (2021–2026)
11.12.5 GenScript Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Gene Site-Directed Mutagenesis Services Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032
Table 2. Key Players of Synonymous Mutations
Table 3. Key Players of Missense Mutation
Table 4. Key Players of Nonsense Mutation
Table 5. Global Gene Site-Directed Mutagenesis Services Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032
Table 6. Global Gene Site-Directed Mutagenesis Services Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 7. Global Gene Site-Directed Mutagenesis Services Market Size by Region (US$ Million), 2021–2026
Table 8. Global Gene Site-Directed Mutagenesis Services Market Share by Region (2021–2026)
Table 9. Global Gene Site-Directed Mutagenesis Services Forecasted Market Size by Region (US$ Million), 2027–2032
Table 10. Global Gene Site-Directed Mutagenesis Services Market Share by Region (2027–2032)
Table 11. Gene Site-Directed Mutagenesis Services Market Trends
Table 12. Gene Site-Directed Mutagenesis Services Market Drivers
Table 13. Gene Site-Directed Mutagenesis Services Market Challenges
Table 14. Gene Site-Directed Mutagenesis Services Market Restraints
Table 15. Global Gene Site-Directed Mutagenesis Services Revenue by Players (US$ Million), 2021–2026
Table 16. Global Gene Site-Directed Mutagenesis Services Market Share by Players (2021–2026)
Table 17. Global Top Gene Site-Directed Mutagenesis Services Players by Tier (Tier 1, Tier 2, and Tier 3), based on Gene Site-Directed Mutagenesis Services Revenue, 2025
Table 18. Ranking of Global Top Gene Site-Directed Mutagenesis Services Companies by Revenue (US$ Million) in 2025
Table 19. Global 5 Largest Players Market Share by Gene Site-Directed Mutagenesis Services Revenue (CR5 and HHI), 2021–2026
Table 20. Global Key Players of Gene Site-Directed Mutagenesis Services, Headquarters and Area Served
Table 21. Global Key Players of Gene Site-Directed Mutagenesis Services, Products and Applications
Table 22. Global Key Players of Gene Site-Directed Mutagenesis Services, Date of General Availability (GA)
Table 23. Mergers and Acquisitions, Expansion Plans
Table 24. Global Gene Site-Directed Mutagenesis Services Market Size by Type (US$ Million), 2021–2026
Table 25. Global Gene Site-Directed Mutagenesis Services Revenue Market Share by Type (2021–2026)
Table 26. Global Gene Site-Directed Mutagenesis Services Forecasted Market Size by Type (US$ Million), 2027–2032
Table 27. Global Gene Site-Directed Mutagenesis Services Revenue Market Share by Type (2027–2032)
Table 28. Global Gene Site-Directed Mutagenesis Services Market Size by Application (US$ Million), 2021–2026
Table 29. Global Gene Site-Directed Mutagenesis Services Revenue Market Share by Application (2021–2026)
Table 30. Global Gene Site-Directed Mutagenesis Services Forecasted Market Size by Application (US$ Million), 2027–2032
Table 31. Global Gene Site-Directed Mutagenesis Services Revenue Market Share by Application (2027–2032)
Table 32. North America Gene Site-Directed Mutagenesis Services Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 33. North America Gene Site-Directed Mutagenesis Services Market Size by Country (US$ Million), 2021–2026
Table 34. North America Gene Site-Directed Mutagenesis Services Market Size by Country (US$ Million), 2027–2032
Table 35. Europe Gene Site-Directed Mutagenesis Services Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 36. Europe Gene Site-Directed Mutagenesis Services Market Size by Country (US$ Million), 2021–2026
Table 37. Europe Gene Site-Directed Mutagenesis Services Market Size by Country (US$ Million), 2027–2032
Table 38. Asia-Pacific Gene Site-Directed Mutagenesis Services Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032
Table 39. Asia-Pacific Gene Site-Directed Mutagenesis Services Market Size by Region (US$ Million), 2021–2026
Table 40. Asia-Pacific Gene Site-Directed Mutagenesis Services Market Size by Region (US$ Million), 2027–2032
Table 41. Latin America Gene Site-Directed Mutagenesis Services Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 42. Latin America Gene Site-Directed Mutagenesis Services Market Size by Country (US$ Million), 2021–2026
Table 43. Latin America Gene Site-Directed Mutagenesis Services Market Size by Country (US$ Million), 2027–2032
Table 44. Middle East & Africa Gene Site-Directed Mutagenesis Services Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 45. Middle East & Africa Gene Site-Directed Mutagenesis Services Market Size by Country (US$ Million), 2021–2026
Table 46. Middle East & Africa Gene Site-Directed Mutagenesis Services Market Size by Country (US$ Million), 2027–2032
Table 47. ACGT Company Details
Table 48. ACGT Business Overview
Table 49. ACGT Gene Site-Directed Mutagenesis Services Product
Table 50. ACGT Revenue in Gene Site-Directed Mutagenesis Services Business (US$ Million), 2021–2026
Table 51. ACGT Recent Development
Table 52. Azenta Life Sciences Company Details
Table 53. Azenta Life Sciences Business Overview
Table 54. Azenta Life Sciences Gene Site-Directed Mutagenesis Services Product
Table 55. Azenta Life Sciences Revenue in Gene Site-Directed Mutagenesis Services Business (US$ Million), 2021–2026
Table 56. Azenta Life Sciences Recent Development
Table 57. Biocompare Company Details
Table 58. Biocompare Business Overview
Table 59. Biocompare Gene Site-Directed Mutagenesis Services Product
Table 60. Biocompare Revenue in Gene Site-Directed Mutagenesis Services Business (US$ Million), 2021–2026
Table 61. Biocompare Recent Development
Table 62. NovoPro Bioscience Inc. Company Details
Table 63. NovoPro Bioscience Inc. Business Overview
Table 64. NovoPro Bioscience Inc. Gene Site-Directed Mutagenesis Services Product
Table 65. NovoPro Bioscience Inc. Revenue in Gene Site-Directed Mutagenesis Services Business (US$ Million), 2021–2026
Table 66. NovoPro Bioscience Inc. Recent Development
Table 67. Charles River Company Details
Table 68. Charles River Business Overview
Table 69. Charles River Gene Site-Directed Mutagenesis Services Product
Table 70. Charles River Revenue in Gene Site-Directed Mutagenesis Services Business (US$ Million), 2021–2026
Table 71. Charles River Recent Development
Table 72. NZYtech Company Details
Table 73. NZYtech Business Overview
Table 74. NZYtech Gene Site-Directed Mutagenesis Services Product
Table 75. NZYtech Revenue in Gene Site-Directed Mutagenesis Services Business (US$ Million), 2021–2026
Table 76. NZYtech Recent Development
Table 77. Thermofisher Company Details
Table 78. Thermofisher Business Overview
Table 79. Thermofisher Gene Site-Directed Mutagenesis Services Product
Table 80. Thermofisher Revenue in Gene Site-Directed Mutagenesis Services Business (US$ Million), 2021–2026
Table 81. Thermofisher Recent Development
Table 82. Creatve Biolabs Company Details
Table 83. Creatve Biolabs Business Overview
Table 84. Creatve Biolabs Gene Site-Directed Mutagenesis Services Product
Table 85. Creatve Biolabs Revenue in Gene Site-Directed Mutagenesis Services Business (US$ Million), 2021–2026
Table 86. Creatve Biolabs Recent Development
Table 87. Epoch Life Science Company Details
Table 88. Epoch Life Science Business Overview
Table 89. Epoch Life Science Gene Site-Directed Mutagenesis Services Product
Table 90. Epoch Life Science Revenue in Gene Site-Directed Mutagenesis Services Business (US$ Million), 2021–2026
Table 91. Epoch Life Science Recent Development
Table 92. GeneToProtein Company Details
Table 93. GeneToProtein Business Overview
Table 94. GeneToProtein Gene Site-Directed Mutagenesis Services Product
Table 95. GeneToProtein Revenue in Gene Site-Directed Mutagenesis Services Business (US$ Million), 2021–2026
Table 96. GeneToProtein Recent Development
Table 97. Genewiz Company Details
Table 98. Genewiz Business Overview
Table 99. Genewiz Gene Site-Directed Mutagenesis Services Product
Table 100. Genewiz Revenue in Gene Site-Directed Mutagenesis Services Business (US$ Million), 2021–2026
Table 101. Genewiz Recent Development
Table 102. GenScript Company Details
Table 103. GenScript Business Overview
Table 104. GenScript Gene Site-Directed Mutagenesis Services Product
Table 105. GenScript Revenue in Gene Site-Directed Mutagenesis Services Business (US$ Million), 2021–2026
Table 106. GenScript Recent Development
Table 107. Research Programs/Design for This Report
Table 108. Key Data Information from Secondary Sources
Table 109. Key Data Information from Primary Sources
Table 110. Authors List of This Report


List of Figures
Figure 1. Gene Site-Directed Mutagenesis Services Picture
Figure 2. Global Gene Site-Directed Mutagenesis Services Market Size Comparison by Type (US$ Million), 2021–2032
Figure 3. Global Gene Site-Directed Mutagenesis Services Market Share by Type: 2025 vs 2032
Figure 4. Synonymous Mutations Features
Figure 5. Missense Mutation Features
Figure 6. Nonsense Mutation Features
Figure 7. Global Gene Site-Directed Mutagenesis Services Market Size by Application (US$ Million), 2021–2032
Figure 8. Global Gene Site-Directed Mutagenesis Services Market Share by Application: 2025 vs 2032
Figure 9. Medical Industry Case Studies
Figure 10. Biological Research Case Studies
Figure 11. Others Case Studies
Figure 12. Gene Site-Directed Mutagenesis Services Report Years Considered
Figure 13. Global Gene Site-Directed Mutagenesis Services Market Size (US$ Million), Year-over-Year: 2021–2032
Figure 14. Global Gene Site-Directed Mutagenesis Services Market Size, (US$ Million), 2021 vs 2025 vs 2032
Figure 15. Global Gene Site-Directed Mutagenesis Services Market Share by Region: 2025 vs 2032
Figure 16. Global Gene Site-Directed Mutagenesis Services Market Share by Players in 2025
Figure 17. Global Gene Site-Directed Mutagenesis Services Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 18. The Top 10 and 5 Players Market Share by Gene Site-Directed Mutagenesis Services Revenue in 2025
Figure 19. North America Gene Site-Directed Mutagenesis Services Market Size YoY Growth (US$ Million), 2021–2032
Figure 20. North America Gene Site-Directed Mutagenesis Services Market Share by Country (2021–2032)
Figure 21. United States Gene Site-Directed Mutagenesis Services Market Size YoY Growth (US$ Million), 2021–2032
Figure 22. Canada Gene Site-Directed Mutagenesis Services Market Size YoY Growth (US$ Million), 2021–2032
Figure 23. Europe Gene Site-Directed Mutagenesis Services Market Size YoY Growth (US$ Million), 2021–2032
Figure 24. Europe Gene Site-Directed Mutagenesis Services Market Share by Country (2021–2032)
Figure 25. Germany Gene Site-Directed Mutagenesis Services Market Size YoY Growth (US$ Million), 2021–2032
Figure 26. France Gene Site-Directed Mutagenesis Services Market Size YoY Growth (US$ Million), 2021–2032
Figure 27. U.K. Gene Site-Directed Mutagenesis Services Market Size YoY Growth (US$ Million), 2021–2032
Figure 28. Italy Gene Site-Directed Mutagenesis Services Market Size YoY Growth (US$ Million), 2021–2032
Figure 29. Russia Gene Site-Directed Mutagenesis Services Market Size YoY Growth (US$ Million), 2021–2032
Figure 30. Ireland Gene Site-Directed Mutagenesis Services Market Size YoY Growth (US$ Million), 2021–2032
Figure 31. Asia-Pacific Gene Site-Directed Mutagenesis Services Market Size YoY Growth (US$ Million), 2021–2032
Figure 32. Asia-Pacific Gene Site-Directed Mutagenesis Services Market Share by Region (2021–2032)
Figure 33. China Gene Site-Directed Mutagenesis Services Market Size YoY Growth (US$ Million), 2021–2032
Figure 34. Japan Gene Site-Directed Mutagenesis Services Market Size YoY Growth (US$ Million), 2021–2032
Figure 35. South Korea Gene Site-Directed Mutagenesis Services Market Size YoY Growth (US$ Million), 2021–2032
Figure 36. Southeast Asia Gene Site-Directed Mutagenesis Services Market Size YoY Growth (US$ Million), 2021–2032
Figure 37. India Gene Site-Directed Mutagenesis Services Market Size YoY Growth (US$ Million), 2021–2032
Figure 38. Australia & New Zealand Gene Site-Directed Mutagenesis Services Market Size YoY Growth (US$ Million), 2021–2032
Figure 39. Latin America Gene Site-Directed Mutagenesis Services Market Size YoY Growth (US$ Million), 2021–2032
Figure 40. Latin America Gene Site-Directed Mutagenesis Services Market Share by Country (2021–2032)
Figure 41. Mexico Gene Site-Directed Mutagenesis Services Market Size YoY Growth (US$ Million), 2021–2032
Figure 42. Brazil Gene Site-Directed Mutagenesis Services Market Size YoY Growth (US$ Million), 2021–2032
Figure 43. Middle East & Africa Gene Site-Directed Mutagenesis Services Market Size YoY Growth (US$ Million), 2021–2032
Figure 44. Middle East & Africa Gene Site-Directed Mutagenesis Services Market Share by Country (2021–2032)
Figure 45. Israel Gene Site-Directed Mutagenesis Services Market Size YoY Growth (US$ Million), 2021–2032
Figure 46. Saudi Arabia Gene Site-Directed Mutagenesis Services Market Size YoY Growth (US$ Million), 2021–2032
Figure 47. UAE Gene Site-Directed Mutagenesis Services Market Size YoY Growth (US$ Million), 2021–2032
Figure 48. ACGT Revenue Growth Rate in Gene Site-Directed Mutagenesis Services Business (2021–2026)
Figure 49. Azenta Life Sciences Revenue Growth Rate in Gene Site-Directed Mutagenesis Services Business (2021–2026)
Figure 50. Biocompare Revenue Growth Rate in Gene Site-Directed Mutagenesis Services Business (2021–2026)
Figure 51. NovoPro Bioscience Inc. Revenue Growth Rate in Gene Site-Directed Mutagenesis Services Business (2021–2026)
Figure 52. Charles River Revenue Growth Rate in Gene Site-Directed Mutagenesis Services Business (2021–2026)
Figure 53. NZYtech Revenue Growth Rate in Gene Site-Directed Mutagenesis Services Business (2021–2026)
Figure 54. Thermofisher Revenue Growth Rate in Gene Site-Directed Mutagenesis Services Business (2021–2026)
Figure 55. Creatve Biolabs Revenue Growth Rate in Gene Site-Directed Mutagenesis Services Business (2021–2026)
Figure 56. Epoch Life Science Revenue Growth Rate in Gene Site-Directed Mutagenesis Services Business (2021–2026)
Figure 57. GeneToProtein Revenue Growth Rate in Gene Site-Directed Mutagenesis Services Business (2021–2026)
Figure 58. Genewiz Revenue Growth Rate in Gene Site-Directed Mutagenesis Services Business (2021–2026)
Figure 59. GenScript Revenue Growth Rate in Gene Site-Directed Mutagenesis Services Business (2021–2026)
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed
Choose Your Edition
Add to cart

Our team would be happy to assist you with your queries.

Contact us

About us

Accurate data, The latest market trends, And deeper research directions.

Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals

Latest reports

Useful links

Our Contacts

Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China

(+86) 159 1069 5232

sales@hengceresearch.com
hengceresearch.com

Allow cookies